IBM Advances to Finals for 2026 ACM Gordon Bell Prize in Protein Modeling
EFG International AG bought 8,693 shares of IBM in the second quarter, valued at about $2.445 million, while Canada Pension Plan Investment Board acquired a new position worth about $481.939 million. IBM, Cleveland Clinic and Japan’s RIKEN advanced to the finals of the 2026 ACM Gordon Bell Prize after using quantum and classical computing to model a 12,635-atom protein.